Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure

Journal of Molecular and Cellular Cardiology

Volumn 39, Issue 4, 2005, Pages 657-665

  Smith, Holly M ^a   Hamblin, Milton ^a   Hill, Michael F ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Antioxidants; Diabetes mellitus; Heart failure; Myocardial infarction; Oxidative stress

Indexed keywords

CATALASE; GLUTATHIONE; ISOPROSTANE DERIVATIVE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART VENTRICLE CONTRACTION; HEART VENTRICLE FUNCTION; LEFT CORONARY ARTERY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

ANIMALS; ANTIOXIDANTS; CARDIAC OUTPUT, LOW; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DINOPROST; GLUTATHIONE DISULFIDE; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDATIVE STRESS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

ANIMALIA;

EID: 24944490072     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2005.07.004     Document Type: Article

References (41)

1. K.J. Mukamal, R.W. Nesto, M.C. Cohen, J.E. Muller, M. Maclure, and J.B. Sherwood Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction Diabetes Care 24 2001 1422 1427
2. S.L. Woodfield, C.F. Lundergan, J.S. Reiner, S.W. Greenhouse, M.A. Thompson, and S.C. Rohrbeck Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience J. Am. Coll. Cardiol. 28 1996 1661 1669
3. G.I. Barbash, H.D. White, M. Modan, and F. Van de Werf Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial J. Am. Coll. Cardiol. 22 1993 707 713
4. R.C. Becker, M. Terrin, R. Ross, G.L. Knatterud, P. Desvigne-Nickens, and J.M. Gore Comparison of clinical outcomes for women and men after acute myocardial infarction. The thrombolysis in myocardial infarction investigators Ann. Intern. Med. 120 1994 638 645
5. K.H. Mak, D.J. Moliterno, C.B. Granger, D.P. Miller, H.D. White, and R.G. Wilcox Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global utilization streptokinase and tissue plasminogen activator for occluded coronary arteries J. Am. Coll. Cardiol. 30 1997 171 179
6. A.S. Jaffe, J.J. Spadaro, K. Schechtman, R. Roberts, E.M. Geltman, and B.E. Sobel Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus Am. Heart J. 108 1984 31 37
7. S.D. Solomon, M. St John Sutton, G.A. Lamas, T. Plappert, J.L. Rouleau, and H. Skali Survival and ventricular enlargement (SAVE) investigators. Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction Circulation 106 2002 1251 1255
8. J.J. Belch, A.B. Bridges, N. Scott, and M. Chopra Oxygen free radicals and congestive heart failure Br. Heart J. 65 1991 245 248
9. N. Singh, A.K. Dhalla, C. Seneviratne, and P.K. Singal Oxidative stress and heart failure Mol. Cell. Biochem. 147 1995 77 81
10. M.F. Hill, and P.K. Singal Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats Am. J. Pathol. 148 1996 291 300
11. A.K. Dhalla, M.F. Hill, and P.K. Singal Role of oxidative stress in transition of hypertrophy to heart failure J. Am. Coll. Cardiol. 28 1996 506 514
12. M.F. Hill, and P.K. Singal Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction Circulation 96 1997 2414 2420
13. N. Khaper, and P.K. Singal Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats J. Am. Coll. Cardiol. 29 1997 856 861
14. P.A. Sobotka, M.D. Brottman, Z. Weitz, A.J. Birnbaum, J.L. Skosey, and E.J. Zarling Elevated breath pentane in heart failure reduced by free radical scavenger Free Radic. Biol. Med. 14 1993 643 647
15. P. Dandona, K. Thusu, S. Cook, B. Snyder, J. Makowski, and D. Armstrong Oxidative damage to DNA in diabetes mellitus Lancet 347 1996 444 445
16. S. Penckofer, D. Schwertz, and K. Florczak Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants J. Cardiovasc. Nurs. 6 2002 68 85
17. Y. Nishio, A. Kashiwagi, H. Taki, K. Shinozaki, Y. Maeno, and H. Kojima Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats Diabetes 47 1998 1318 1325
18. S.A. Wohaieb, and D.V. Godin Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat Can. J. Physiol. Pharmacol. 65 1987 2191 2195
19. S.A. Wohaieb, and D.V. Godin Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment Diabetes 36 1987 1014 1018
20. Q. Liang, E.C. Carlson, R.V. Donthi, P.M. Kralik, X. Shen, and P.N. Epstein Overexpression of metallothionein reduces diabetic cardiomyopathy Diabetes 51 2002 174 181
21. B.M. Matata, and M. Galinanes Cardiopulmonary bypass exacerbates oxidative stress but does not increase proinflammatory cytokine release in patients with diabetes compared with patients without diabetes: regulatory effects of exogenous nitric oxide J. Thorac. Cardiovasc. Surg. 120 2000 1 11
22. A. Nadeau, G. Tancrede, and S. Rousseau-Migneron Acute diabetes mellitus does not impair survival rate in rats submitted to left coronary artery ligation Can. J. Cardiol. 3 1987 90 93
23. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease: the Framingham study JAMA 241 1979 2035 2038
24. H.C. Yeo, H.J. Helbock, D.W. Chyu, and B.N. Ames Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry Anal. Biochem. 220 1994 391 396
25. nd A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc. Natl. Acad. Sci. USA 87 1990 9383 9387
26. N. Delanty, M.P. Reilly, D. Pratico, J.A. Lawson, J.F. McCarthy, and A.E. Wood 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo Circulation 95 1997 2492 2499
27. S.K. Jain, and S.N. Levine Elevated lipid peroxidation and vitamin E-quinone levels in heart ventricles of streptozotocin-treated diabetic rats Free Radic. Biol. Med. 18 1995 337 341
28. F.S. Fein, B.E. Zola, A. Malhotra, S. Cho, S.M. Factor, and J. Scheuer Hypertensive-diabetic cardiomyopathy in rats Am. J. Physiol. 258 1990 H793 H805
29. F.S. Fein, L.B. Kornstein, J.E. Strobeck, J.M. Capasso, and E.H. Sonnenblick Altered myocardial mechanics in diabetic rats Circ. Res. 47 1980 922 933
30. B.M. Kromer, and J.R. Tippins Coronary artery constriction by the isoprostane 8-epiprostaglandin F2 alpha Br. J. Pharmacol. 119 1996 1276 1280
31. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
32. T.J. Guzik, N.E. West, E. Black, D. McDonald, C. Ratnatunga, and R. Pillai Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors Circ. Res. 86 2000 E85 E90
33. J.H. Doroshow, G.Y. Locker, and C.E. Myers Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin J. Clin. Invest. 65 1980 128 135
34. P.K. Singal, A.K. Dhalla, M. Hill, and T.P. Thomas Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions Mol. Cell. Biochem. 129 1993 179 186
35. C.C. Lai, M. Peng, L. Huang, W.H. Huang, and T.H. Chiu Chronic exposure of neonatal cardiac myocytes to hydrogen peroxide enhances the expression of catalase J. Mol. Cell. Cardiol. 28 1996 1157 1163
36. S. Dieterich, U. Bieligk, K. Beulich, G. Hasenfuss, and J. Prestle Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart Circulation 101 2000 33 39
37. F. Cosentino, K. Hishikawa, Z.S. Katusic, and T.F. Luscher High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells Circulation 96 1997 25 28
38. H. Ischiropoulos, L. Zhu, J. Chen, M. Tsai, J.C. Martin, and C.D. Smith Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase Arch. Biochem. Biophys. 298 1992 431 437
39. F.S. Fein, J.E. Strobeck, A. Malhotra, J. Scheuer, and E.H. Sonnenblick Reversibility of diabetic cardiomyopathy with insulin in rats Circ. Res. 49 1981 1251 1261
40. S. Penpargkul, T. Schaible, T. Yipintsoi, and J. Scheuer The effect of diabetes on performance and metabolism of rat hearts Circ. Res. 47 1980 911 921
41. 2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes Proc. Natl. Acad. Sci. USA 80 1983 5412 5416